Skip to main content
Clinical Trials/NCT03248830
NCT03248830
Completed
N/A

Evaluation of Non-invasive Hemoglobin Monitoring in Children With Congenital Heart Diseases

Cairo University1 site in 1 country56 target enrollmentFebruary 20, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
Cairo University
Enrollment
56
Locations
1
Primary Endpoint
non-invasive hemoglobin
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The investigators will evaluate the accuracy of non-invasive hemoglobin monitor (Sp-Hb) compared to traditional laboratory hemoglobin (Lab-Hb) in children with congenital heart disease. The investigators will also compare the accuracy of Sp-Hb in cyanotic children to acyanotic children.

Detailed Description

Blood hemoglobin is measured daily in clinical practice. Laboratory measurement (Lab-Hb) of is the gold standard for assessment of blood hemoglobin. Recently, non-invasive monitors had been introduced. Non-invasive measurement of hemoglobin (Sp-Hb) would save time and minimize the risk of infection. Blood sampling in children is usually more difficult and stressful; moreover, it also carries the risk of iatrogenic anemia. Radical-7 (Masimo corporation, Irvine, CA) is a device that operates using the principle of co-oximetry . Radical-7 had been validated in various clinical purposes. Measurement of blood hemoglobin is an important application for Radical-7 device. Non-invasive hemoglobin (Sp-Hb) measurement has been frequently validated in adults; as well as in pediatric patients; however, its accuracy in children with congenital heart disease was not investigated. Congenital heart disease infants usually undergo major operations and frequently need transfusion of blood. Moreover, these patients have special circulatory physiology that might impact the device accuracy. It had been recently reported that the performance of co-oximetry in congenital heart disease children is poor in measurement of oxygen saturation specially at oxygen saturation under 75%; however, its accuracy in measurement of hemoglobin was not investigated yet. In this study, the investigators will evaluate the accuracy of Sp-Hb compared to traditional Lab-Hb in children with congenital heart disease. the investigators will also compare the accuracy of Sp-Hb in cyanotic children to acyanotic children.

Registry
clinicaltrials.gov
Start Date
February 20, 2018
End Date
September 10, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Hasanin

Assistant professor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • infants and children less than 8 years
  • with congenital heart disease

Exclusion Criteria

  • refusal of the patient surrogate to share in the study

Outcomes

Primary Outcomes

non-invasive hemoglobin

Time Frame: 5 hours

the value of hemoglobin measured by radical-7 device in g/dL

Secondary Outcomes

  • laboratory hemoglobin(5 hours)
  • systolic blood pressure(5 hours)
  • heart rate(5 hours)
  • perfusion index(5 hours)
  • plethysmography variability index(5 hours)
  • diastolic blood pressure(5 hours)
  • oxygen saturation from radical-7 device(5 hours)
  • oxygen saturation from arterial blood gases(5 hours)

Study Sites (1)

Loading locations...

Similar Trials